Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinicopathological Features and Survival Rate of Colorectal Adenocarcinoma Patients with and without a KRAS Mutation: a FiveYear Study in Yazd, Iran.

Asian Pacific journal of cancer prevention : APJCP - 1 Jan 2016

Zahir Shokouh Taghipour, NazemianYazdi Mohammadreza, Arasteh Peyman, Mortazavizadeh Mohammadreza, Karbalaeian Mohammad, ZareMehrjardi Malihe

Abstract excerpt

BACKGROUND: By some estimates, colorectal carcinoma is the third most common cancer worldwide. The most appropriate method of treatment, especially of its metastatic form, is determined based on KRAS status. The present study was conducted on patients with colorectal cancer positive or neagtive for a KRAS mutation in terms of survival rate and the response to treatment. MATERIALS AND METHODS: Medical records of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colorectal Neoplasms

Share to Neoplasm Staging

Share to Proto-Oncogene Proteins p21(ras)

Share to Survival Analysis

Share to Survival Rate

Source

Identifiers

PMID: 27509985

Genes

KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinicopathological Features and Survival Rate of Colorectal Adenocarcinoma Patients with and without a KRAS Mutation: a FiveYear Study in Yazd, Iran.PMID 27509985Read ↗

Prevalence of colorectal cancer biomarkers and their impact on clinical outcomes in Riyadh, Saudi Arabia.Semantic proximity Read ↗

The association of clinicopathological features and survival in colorectal cancer patients with kras mutation status.Semantic proximity Read ↗

Mutation Status and Prognostic Value of KRAS and BRAF in Southeast Iranian Colorectal Cancer Patients: First Report from Southeast of Iran.Semantic proximity Read ↗

Prognostic Value of KRAS Mutations in Colorectal Cancer PatientsSemantic proximity Read ↗

KRAS Mutation: Characterization and Its Impact on Survival Outcome of Patients with Metastatic Colorectal Cancer.Semantic proximity Read ↗

Association between clinicopathological characteristics and RAS mutation in colorectal cancer.Semantic proximity Read ↗

Relationship Between KRAS Gene Mutation Status and Clinicopathological Features of Colorectal Cancer Patients in MakassarSemantic proximity Read ↗

Clinicopathological Features of KRAS-Mutated Colon Cancer: An Analytical Cross-Sectional StudySemantic proximity Read ↗

Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer.Semantic proximity Read ↗

The Prognostic Impact of KRAS G12C Mutation in Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Observational Study.Semantic proximity Read ↗

KRAS Mutation Status as a Prognostic Marker and Predictor of Therapy Response in Colorectal Cancer: an NCDB Analysis.Semantic proximity Read ↗

Activating KRAS mutation is prognostic only among patients who receive preoperative chemotherapy before resection of colorectal liver metastases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.